Neuro-Behçet's disease (NBD) is one of the more serious manifestations of Behçet's disease
(BD), which is a relapsing inflammatory multisystem disease with an interesting …

Neuro-Behcet's disease (NBD) is defined as a combination of neurologic symptoms and/or
signs in a patient with Behcet's disease (BD). Relevant syndromes include brainstem …

Objectives: To develop evidence-based European League Against Rheumatism (EULAR)
recommendations for the management of Behçet disease (BD) supplemented where …

Objective To report the efficacy and safety of anti-TNF agents in patients with severe and/or
refractory manifestations of Behçet's disease (BD). Methods We performed a multicenter …

OBJECTIVE:: Off-label use of anti-tumor necrosis factor (TNF) agents for Behçet's disease
(BD) is increasing. We evaluated published data on their efficacy and safety for patients with …

Tumor necrosis factor-alpha (TNF-α) is a pleiotropic immune cytokine that belongs to the
TNF superfamily of receptor ligands. The cytokine exists as either a transmembrane or a …

Objectives To describe the response to IL-6 blockade [tocilizumab (TCZ)] in three patients
affected by highly refractory neuro-Behçet disease (NBD). Methods Three patients who had …

Objective: We evaluated the effectiveness of infliximab in patients with neuro-Behçet
syndrome for whom other immunosuppressive medications had failed. Methods: Patients …

Introduction: Etanercept is a tumor necrosis factor alpha (TNF-α) inhibitor, which is approved
for the treatment of immune-mediated inflammatory conditions including rheumatoid arthritis …

Tumoral necrosis factor α plays a central role in both the inflammatory response and that of
the immune system. Thus, its blockade with the so‐called anti‐TNF agents (infliximab …